综述 |
|
|
|
|
促凋亡蛋白BAK的功能及在病毒感染中作用的研究进展* |
徐炜民,邓鑫,伍锐**() |
四川农业大学动物医学院 猪病研究中心 成都 610000 |
|
Research Progress on the Function of Pro-apoptotic Protein BAK and Its Role in Virus Infection |
XU Wei-min,DENG Xin,WU Rui**() |
Research Center of Swine Diseases, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu 610000, China |
[1] |
Willis S N, Fletcher J I, Kaufmann T, et al. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science, 2007, 315(5813): 856-859.
doi: 10.1126/science.1133289
pmid: 17289999
|
[2] |
Brooks C, Wei Q Q, Feng L P, et al. Bak regulates mitochondrial morphology and pathology during apoptosis by interacting with mitofusins. Proceedings of the National Academy of Sciences of the United States of America, 2007, 104(28): 11649-11654.
|
[3] |
Vince J E, De Nardo D, Gao W Q, et al. The mitochondrial apoptotic effectors BAX/BAK activate caspase-3 and-7 to trigger NLRP 3 inflammasome and caspase-8 driven IL-1β activation. Cell Reports, 2018, 25(9): 2339-2353.e4.
doi: 10.1016/j.celrep.2018.10.103
|
[4] |
Edlich F. BCL-2 proteins and apoptosis: recent insights and unknowns. Biochemical and Biophysical Research Communications, 2018, 500(1): 26-34.
doi: S0006-291X(17)31321-9
pmid: 28676391
|
[5] |
Pogmore J P, Uehling D, Andrews D W. Pharmacological targeting of executioner proteins: controlling life and death. Journal of Medicinal Chemistry, 2021, 64(9): 5276-5290.
doi: 10.1021/acs.jmedchem.0c02200
pmid: 33939407
|
[6] |
Glab J A, Cao Z P, Puthalakath H. Bcl-2 family proteins, beyond the veil. International Review of Cell and Molecular Biology, 2020, 351: 1-22.
doi: S1937-6448(19)30120-0
pmid: 32247577
|
[7] |
Huang K, O’Neill K L, Li J, et al. BH3-only proteins target BCL-xL/MCL-1, not BAX/BAK, to initiate apoptosis. Cell Research, 2019, 29(11): 942-952.
doi: 10.1038/s41422-019-0231-y
pmid: 31551537
|
[8] |
Adams J M. BAX and BAK become killers without a BH3 trigger. Cell Research, 2019, 29(12): 967-968.
doi: 10.1038/s41422-019-0253-5
pmid: 31729467
|
[9] |
Heimer S, Knoll G, Schulze-Osthoff K, et al. Raptinal bypasses BAX, BAK, and BOK for mitochondrial outer membrane permeabilization and intrinsic apoptosis. Cell Death & Disease, 2019, 10: 556.
|
[10] |
Hockings C, Alsop A E, Fennell S C, et al. Mcl-1 and Bcl-xL sequestration of Bak confers differential resistance to BH3-only proteins. Cell Death & Differentiation, 2018, 25(4): 721-734.
|
[11] |
Huska J D, Lamb H M, Hardwick J M. Overview of BCL-2 family proteins and therapeutic potentials. Methods in Molecular Biology (Clifton, N J), 2019, 1877: 1-21.
|
[12] |
Luo X, O’Neill K L, Huang K. The third model of Bax/Bak activation: a Bcl-2 family feud finally resolved? F1000Res, 2020, 9: 935.
doi: 10.12688/f1000research
|
[13] |
Peña-Blanco A, García-Sáez A J. Bax, bak and beyond - mitochondrial performance in apoptosis. The FEBS Journal, 2018, 285(3): 416-431.
doi: 10.1111/febs.2018.285.issue-3
|
[14] |
Voss A K, Strasser A. The essentials of developmental apoptosis. F1000Res, 2020, 9: 148.
doi: 10.12688/f1000research
|
[15] |
Iyer S, Uren R T, Dengler M A, et al. Robust autoactivation for apoptosis by BAK but not BAX highlights BAK as an important therapeutic target. Cell Death & Disease, 2020, 11: 268.
|
[16] |
de Torre-Minguela C, Gómez A I, Couillin I, et al. Gasdermins mediate cellular release of mitochondrial DNA during pyroptosis and apoptosis. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 2021, 35(8): e21757.
|
[17] |
Zhang Y, Iqbal S, O’Leary M F N, et al. Altered mitochondrial morphology and defective protein import reveal novel roles for Bax and/or Bak in skeletal muscle. American Journal of Physiology Cell Physiology, 2013, 305(5): C502-C511.
doi: 10.1152/ajpcell.00058.2013
|
[18] |
Hu L, Chen M, Chen X R, et al. Chemotherapy-induced pyroptosis is mediated by BAK/BAX-caspase-3-GSDME pathway and inhibited by 2-bromopalmitate. Cell Death & Disease, 2020, 11: 281.
|
[19] |
Flores-Romero H, Ros U, Garcia-Saez A J. Pore formation in regulated cell death. The EMBO Journal, 2020, 39(23): e105753.
|
[20] |
Wei M C, Zong W X, Cheng E H, et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science, 2001, 292(5517): 727-730.
doi: 10.1126/science.1059108
pmid: 11326099
|
[21] |
Moldoveanu T, Czabotar P E. BAX, BAK, and BOK: a coming of age for the BCL-2 family effector proteins. Cold Spring Harbor Perspectives in Biology, 2020, 12(4): a036319.
doi: 10.1101/cshperspect.a036319
|
[22] |
Singh G, Moldoveanu T. Methods to probe conformational activation and mitochondrial activity of proapoptotic BAK. Methods in Molecular Biology. New York: Springer New York, 2018: 185-200.
|
[23] |
Iyer S, Uren R T, Kluck R M. Probing BAK and BAX activation and pore assembly with cytochrome c release, limited proteolysis, and oxidant-induced linkage. Methods in Molecular Biology (Clifton, N J), 2019, 1877: 201-216.
|
[24] |
Galluzzi L, Vanpouille-Box C. BAX and BAK at the gates of innate immunity. Trends in Cell Biology, 2018, 28(5): 343-345.
doi: S0962-8924(18)30034-5
pmid: 29555208
|
[25] |
Li M X, Tan I K L, Ma S B, et al. BAK α6 permits activation by BH3-only proteins and homooligomerization via the canonical hydrophobic groove. Proceedings of the National Academy of Sciences of the United States of America, 2017, 114(29): 7629-7634.
|
[26] |
Westphal D, Dewson G, Czabotar P E, et al. Molecular biology of Bax and Bak activation and action. Biochimica et Biophysica Acta, 2011, 1813(4): 521-531.
doi: 10.1016/j.bbamcr.2010.12.019
pmid: 21195116
|
[27] |
Ye K Q, Meng W X, Sun H B, et al. Characterization of an alternative BAK-binding site for BH3 peptides. Nature Communications, 2020, 11: 3301.
doi: 10.1038/s41467-020-17074-y
pmid: 32620849
|
[28] |
McArthur K, Whitehead L W, Heddleston J M, et al. BAK/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis. Science, 2018, 359(6378): eaao6047.
doi: 10.1126/science.aao6047
|
[29] |
Vila-Julià G, Granadino-Roldán J M, Perez J J, et al. Molecular determinants for the activation/inhibition of Bak protein by BH 3 peptides. Journal of Chemical Information and Modeling, 2020, 60(3): 1632-1643.
doi: 10.1021/acs.jcim.9b01047
pmid: 31944696
|
[30] |
Dewson G, Kluck R M. Mechanisms by which Bak and Bax permeabilise mitochondria during apoptosis. Journal of Cell Science, 2009, 122(Pt 16): 2801-2808.
doi: 10.1242/jcs.038166
pmid: 19795525
|
[31] |
Dewson G, Kratina T, Sim H W, et al. To trigger apoptosis, Bak exposes its BH 3 domain and homodimerizes via BH3: groove interactions. Molecular Cell, 2008, 30(3): 369-380.
doi: 10.1016/j.molcel.2008.04.005
pmid: 18471982
|
[32] |
Mandal T, Shin S, Aluvila S, et al. Assembly of Bak homodimers into higher order homooligomers in the mitochondrial apoptotic pore. Scientific Reports, 2016, 6: 30763.
doi: 10.1038/srep30763
pmid: 27488021
|
[33] |
Li K M, van Delft M F, Dewson G. Too much death can kill You: inhibiting intrinsic apoptosis to treat disease. The EMBO Journal, 2021, 40(14): e107341.
|
[34] |
Surman D R, Xu Y, Lee M J, et al. Therapeutic synergy in esophageal cancer and mesothelioma is predicted by dynamic BH3 profiling. Molecular Cancer Therapeutics, 2021, 20(8): 1469-1480.
doi: 10.1158/1535-7163.MCT-20-0887
pmid: 34088830
|
[35] |
Tran V H, Bartolo R, Westphal D, et al. Bak apoptotic function is not directly regulated by phosphorylation. Cell Death & Disease, 2013, 4(1): e452.
|
[36] |
Uren R T, Iyer S, Kluck R M. Pore formation by dimeric Bak and Bax: an unusual pore? Philosophical Transactions of the Royal Society of London Series B, Biological Sciences, 2017, 372(1726): 20160218.
|
[37] |
Birkinshaw R W, Iyer S, Lio D, et al. Structure of detergent-activated BAK dimers derived from the inert monomer. Molecular Cell, 2021, 81(10): 2123-2134.e5.
doi: 10.1016/j.molcel.2021.03.014
pmid: 33794146
|
[38] |
Cuconati A, Degenhardt K, Sundararajan R, et al. Bak and Bax function to limit adenovirus replication through apoptosis induction. Journal of Virology, 2002, 76(9): 4547-4558.
pmid: 11932420
|
[39] |
Pérez-Treviño P, Velásquez M, García N. Mechanisms of mitochondrial DNA escape and its relationship with different metabolic diseases. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 2020, 1866(6): 165761.
|
[40] |
Lee E F, Grabow S, Chappaz S, et al. Physiological restraint of Bak by Bcl-xL is essential for cell survival. Genes & Development, 2016, 30(10): 1240-1250.
doi: 10.1101/gad.279414.116
|
[41] |
Korsmeyer S J, Wei M C, Saito M, et al. Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death & Differentiation, 2000, 7(12): 1166-1173.
|
[42] |
Sandow J J, Tan I K, Huang A S, et al. Dynamic reconfiguration of pro-apoptotic BAK on membranes. The EMBO Journal, 2021, 40(20): e107237.
|
[43] |
Yeganeh B, Ghavami S, Rahim M N, et al. Autophagy activation is required for influenza A virus-induced apoptosis and replication. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 2018, 1865(2): 364-378.
doi: 10.1016/j.bbamcr.2017.10.014
|
[44] |
Lin L, Zhang M, Stoilov P, et al. Developmental attenuation of neuronal apoptosis by neural-specific splicing of Bak1 microexon. Neuron, 2020, 107(6): 1180-1196.e8.
doi: S0896-6273(20)30490-6
pmid: 32710818
|
[45] |
Imao T, Nagata S. Apaf-1- and caspase-8-independent apoptosis. Cell Death and Differentiation, 2013, 20(2): 343-352.
doi: 10.1038/cdd.2012.149
pmid: 23197294
|
[46] |
Huang K, Zhang J J, O’Neill K L, et al. Cleavage by caspase 8 and mitochondrial membrane association activate the BH3-only protein bid during TRAIL-induced apoptosis. Journal of Biological Chemistry, 2016, 291(22): 11843-11851.
doi: 10.1074/jbc.M115.711051
pmid: 27053107
|
[47] |
Simpson D S, Pang J Y, Weir A, et al. Interferon-γ primes macrophages for pathogen ligand-induced killing via a caspase-8 and mitochondrial cell death pathway. Immunity, 2022, 55(3): 423-441.e9.
doi: 10.1016/j.immuni.2022.01.003
pmid: 35139355
|
[48] |
Chen W T, Hsu F T, Liu Y C, et al. Fluoxetine induces apoptosis through extrinsic/intrinsic pathways and inhibits ERK/NF-κB-modulated anti-apoptotic and invasive potential in hepatocellular carcinoma cells in vitro. International Journal of Molecular Sciences, 2019, 20(3): 757.
doi: 10.3390/ijms20030757
|
[49] |
Galluzzi L, Morselli E, Kepp O, et al. Targeting p53 to mitochondria for cancer therapy. Cell Cycle, 2008, 7(13): 1949-1955.
pmid: 18642442
|
[50] |
Nieminen A I, Eskelinen V M, Haikala H M, et al. Myc-induced AMPK-phospho p53 pathway activates Bak to sensitize mitochondrial apoptosis. Proceedings of the National Academy of Sciences of the United States of America, 2013, 110(20): E 1839-E1848.
|
[51] |
Zhang J, Huang K, O’Neill K L, et al. Bax/Bak activation in the absence of Bid, Bim, Puma, and p53. Cell Death & Disease, 2016, 7(6): e2266.
|
[52] |
Degenhardt K, Chen G H, Lindsten T, et al. BAX and BAK mediate p53-independent suppression of tumorigenesis. Cancer Cell, 2002, 2(3): 193-203.
pmid: 12242152
|
[53] |
Wang J J, Guo W H, Zhou H, et al. Mitochondrial p53 phosphorylation induces Bak-mediated and caspase-independent cell death. Oncotarget, 2015, 6(19): 17192-17205.
pmid: 25980443
|
[54] |
Leu JI-Ju, George D L. Hepatic IGFBP1 is a prosurvival factor that binds to BAK, protects the liver from apoptosis, and antagonizes the proapoptotic actions of p53 at mitochondria. Genes & Development, 2007, 21(23): 3095-3109.
doi: 10.1101/gad.1567107
|
[55] |
Chin H S, Li M X, Tan I K L, et al. VDAC2 enables BAX to mediate apoptosis and limit tumor development. Nature Communications, 2018, 9: 4976.
doi: 10.1038/s41467-018-07309-4
pmid: 30478310
|
[56] |
Dudko H V, Urban V A, Davidovskii A I, et al. Structure-based modeling of turnover of Bcl-2 family proteins bound to voltage-dependent anion channel 2 (VDAC2): implications for the mechanisms of proapoptotic activation of Bak and Bax in vivo. Computational Biology and Chemistry, 2020, 85: 107203.
doi: 10.1016/j.compbiolchem.2020.107203
|
[57] |
Sundararajan R, Cuconati A, Nelson D, et al. Tumor necrosis factor-alpha induces Bax-Bak interaction and apoptosis, which is inhibited by adenovirus E1B 19K. The Journal of Biological Chemistry, 2001, 276(48): 45120-45127.
doi: 10.1074/jbc.M106386200
|
[58] |
Cheng Y, Sun F, Wang L, et al. Virus-induced p38 MAPK activation facilitates viral infection. Theranostics, 2020, 10(26): 12223-12240.
doi: 10.7150/thno.50992
pmid: 33204339
|
[59] |
Li S F, Li H, Zhang Y L, et al. SFTSV infection induces BAK/BAX-dependent mitochondrial DNA release to trigger NLRP 3 inflammasome activation. Cell Reports, 2020, 30(13): 4370-4385.
doi: 10.1016/j.celrep.2020.02.105
|
[60] |
Urban C, Rhême C, Maerz S, et al. Apoptosis induced by Semliki Forest virus is RNA replication dependent and mediated via Bak. Cell Death & Differentiation, 2008, 15(9): 1396-1407.
|
[61] |
Zhong Y X, Liao Y, Fang S G, et al. Up-regulation of Mcl-1 and Bak by coronavirus infection of human, avian and animal cells modulates apoptosis and viral replication. PLoS One, 2012, 7(1): e30191.
doi: 10.1371/journal.pone.0030191
|
[62] |
Suzuki T, Okamoto T, Katoh H, et al. Infection with flaviviruses requires BCLXL for cell survival. PLoS Pathogens, 2018, 14(9): e1007299.
doi: 10.1371/journal.ppat.1007299
|
[63] |
Pearce A F, Lyles D S. Vesicular stomatitis virus induces apoptosis primarily through Bak rather than Bax by inactivating Mcl-1 and Bcl-XL. Journal of Virology, 2009, 83(18): 9102-9112.
doi: 10.1128/JVI.00436-09
pmid: 19587033
|
[64] |
Cosentino K, Hertlein V, Jenner A, et al. The interplay between BAX and BAK tunes apoptotic pore growth to control mitochondrial-DNA-mediated inflammation. Molecular Cell, 2022, 82(5): 933-949.e9.
doi: 10.1016/j.molcel.2022.01.008
pmid: 35120587
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|